QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NUVB

QT69Nuvation Bio Inc.
NYSE·Healthcare·Biotechnology·USA
Latest market price
5.56
+0.23+4.32%
OverviewShort InterestFilings
NUVBQT69Nuvation Bio Inc.·NYSE
OverviewShort InterestFilings
5.56+4.32%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.43
Insider Own43.62%
Shs Outstand348.20M
Perf Week16.81%
Market Cap1.85BForward P/E-EPS next Y-0.26Insider Trans0.09%Shs Float-Perf Month31.13%
Enterprise Value1.74BPEG-EPS next Q-0.15Inst Own-Short Float-Perf Quarter30.52%
Income-146011275.00P/S12.94EPS this Y17.39%Inst Trans-Short Ratio-Perf Half Y-35.80%
Sales143.05MP/B5.79EPS next Y26.06%ROA-23.92%Short Interest-Perf YTD-37.95%
Book/sh0.92P/C-EPS next 5Y-ROE-44.10%52W High9.75 -42.97%Perf Year225.15%
Cash/sh1.53P/FCF-EPS past 3/5Y-ROIC-27.90%52W Low1.58 251.90%Perf 3Y-
Dividend Est.-EV/EBITDA-13.37Sales past 3/5Y-Gross Margin91.64%Volatility3.98% 5.47%Perf 5Y-
Dividend TTM-EV/Sales12.13EPS Y/Y TTM79.62%Oper. Margin-104.99%ATR (14)0.34Perf 10Y-
Dividend Ex-Date-Quick Ratio7.24Sales Y/Y TTM1687.50%Profit Margin-102.06%RSI (14)65.41Recom2.00
Dividend Gr. 3/5Y-Current Ratio7.44EPS Q/Q106.25%SMA2013.26%Beta2.11Target Price13.00
Payout0.00%Debt/Eq0.03Sales Q/Q2666.67%SMA5016.02%Rel Volume1.10Prev Close5.33
Employees273LT Debt/Eq0.01EarningsAug 06SMA2004.48%Avg Volume4.29MPrice5.56
IPO DateAug 26, 2020Option/ShortYes / YesEPS/Sales Surpr.-91.67% 25.76%Net Debt/EBITDA0.89Volume4,722,291Change4.32%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-27-26ReiteratedTruist Financial$11 → $13
Jan-21-26ReiteratedRBC CapitalOutperform$5.00 → $12
Jan-12-26ReiteratedH.C. Wainwright$18 → $17
Jan-07-26ReiteratedUBS$10
Dec-11-25ReiteratedH.C. Wainwright$10 → $18
Dec-01-25ReiteratedH.C. Wainwright$7.00 → $10
Nov-24-25InitiatedTruistBuy$11
Nov-20-25ReiteratedJMP SecuritiesMarket Outperform$8.00 → $10
Nov-04-25ReiteratedJMP SecuritiesMarket Outperform$6.00 → $8.00
Apr-23-25InitiatedCitizens JMPOutperform$6.00
Latest News
Jun-15-26
Jun-15-2610:38AM
Nuvation Bio: David Hung's Latest Venture Looks Undervalued At Current LevelSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue143638
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1287
Gross Profit131541
Selling, General and Administrative Excl. Other15315269
Research and Development125115524
Other Operating Expense310
Operating Income-150-213-593
Interest Expense21140
Unusual Expense
———
Non-Operating Income (Expense)-18-22-25
Net Income Before Taxes-147-205-568
Income Taxes
000
Consolidated Net Income-147-205-568
Net Income From Continuing Operations-147-205-568
Net Income-147-205-568
EPS (Recurring)-0.42-0.60-2.11
EPS (Basic, Before Extraordinaries)-0.42-0.60-2.11
EPS (Diluted)-0.43-0.60-2.11
EBITDA-129-189-567
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio13.4948.64—
Gross Margin91.6185.7112.50
Operating Margin-104.90-338.10-7,412.50
Net Margin-102.80-325.40-7,100.00
Shares Outstanding347342269
Market Capitalization1,9293,064—
Operating Lease Expense
———
Insider Trading Volume
$6.09$5.68$5.28$4.87$4.46● Close Price0.00M1.01M2.02M3.03M4.04MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Mashal RobertDirectorJun 09 '26Buy4.7325,000118,250225,000Jun 11 12:00 AM
Wentworth KerryCHIEF REGULATORY OFFICERApr 17 '26Option Exercise2.9373,500215,356215,250Apr 21 12:00 AM
Wentworth KerryCHIEF REGULATORY OFFICERApr 17 '26Sale5.0136,750184,27953,000Apr 21 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERApr 17 '26Option Exercise1.94100,000194,000430,000Apr 21 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERApr 17 '26Sale5.0250,000251,00018,000Apr 21 12:00 AM
Wentworth KerryCHIEF REGULATORY OFFICERApr 06 '26Option Exercise1.91400,000762,000400,000Apr 08 12:00 AM
Wentworth KerryCHIEF REGULATORY OFFICERApr 06 '26Sale4.52200,000903,56053,000Apr 08 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERDec 01 '25Option Exercise2.93300,000879,000168,000Dec 03 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERDec 01 '25Sale7.82150,0001,173,25518,000Dec 03 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERNov 26 '25Sale8.0010,00080,00018,000Nov 26 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERNov 26 '25Option Exercise3.6120,00072,200470,000Nov 26 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERNov 25 '25Option Exercise3.6110,00036,100480,000Nov 26 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERNov 25 '25Sale7.5010,00075,00018,000Nov 26 12:00 AM
Hattersley GaryCHIEF SCIENTIFIC OFFICERNov 20 '25Sale7.23300,0002,168,1000Nov 24 12:00 AM
Liu DongfangCHIEF MEDICAL OFFICERNov 20 '25Option Exercise1.8740,00074,800450,000Nov 24 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR